Telik and MabVax Therapeutics Announce Definitive Merger Agreement

[PR Newswire] – PALO ALTO, Calif., May 12, 2014 /PRNewswire/ — Telik, Inc. (TELK), a clinical stage oncology drug development company, and MabVax Therapeutics, Inc., a privately held cancer immunotherapy company, have entered into a definitive merger ag more

View todays social media effects on TELK

View the latest stocks trending across Twitter. Click to view dashboard

See who Telik is hiring next, click here to view